Post-Authorization Long Term Safety Surveillance Study of Fostamatinib in Adult Patients with Chronic Immune Thrombocytopenia (cITP) who are Refractory to Previous Treatments First published 22/07/2021 Last updated 11/01/2022 EU PAS number:EUPAS42043 Study Planned